US Stock MarketDetailed Quotes
OPTN OptiNose
- 1.060
- -0.080-7.02%
Trading May 7 09:51 ET
119.82MMarket Cap-3312P/E (TTM)
1.150High1.040Low126.99KVolume1.150Open1.140Pre Close138.61KTurnover0.15%Turnover RatioLossP/E (Static)113.04MShares2.10052wk High-1.38P/B87.51MFloat Cap0.80052wk Low--Dividend TTM82.56MShs Float30.000Historical High--Div YieldTTM9.65%Amplitude0.800Historical Low1.091Avg Price1Lot Size
About OptiNose Company
OptiNose, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in October 2000 and is headquartered in Yardley, PA.
Company Profile
SymbolOPTN
Company NameOptiNose
Listing DateOct 13, 2017
Issue Price16.00
Founded2000
CEODr. Ramy A. Mahmoud, M.D.
MarketNASDAQ
Employees132
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1020 Stony Hill Road,Suite 300
CityYardley
ProvincePennsylvania
CountryUnited States of America
Zip Code19067
Phone1-267-364-3500
Websitehttp://www.optinose.com
Company Executives
- Name
- Position
- Salary
- Dr. Ramy A. Mahmoud, M.D.
- Chief Executive Officer and Director
- 2.41M
- Paul Spence, Jr
- Chief Commercial Officer
- 664.02K
- Michael F. Marino, III,
- Chief Legal Officer and Corporate Secretary
- 1.32M
- Anthony J. Krick
- Principal Financial Officer, Vice President, Finance and Chief Accounting Officer
- --
- R. John Fletcher
- Chairman of the Board
- 120.22K
- Sandra L. Helton
- Independent Director
- 103.42K
- Kyle Dempsey
- Independent Director
- 90.92K
- Catherine E. Owen
- Independent Director
- 89.95K
- Tomas J. Heyman
- Independent Director
- 96.88K
- Wilhelmus C. M. Groenhuysen
- Independent Director
- 100.92K
- Dr. Eric Bednarski
- Independent Director
- 88.42K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
